Ticker Details
VYNE Therapeutics Inc.
IPO Date:	January 22, 2018
Sector:	Healthcare
Market Cap:	$19.64M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.10 | 4.19%
Avg Daily Range (30 D):	$0.01 | 2.15%
Avg Daily Range (90 D):	$0.02 | 3.36%

Institutional Daily Volume
Avg Daily Volume:	.81M
Avg Daily Volume (30 D):	.42M
Avg Daily Volume (90 D):	4.02M

Trade Size
Avg Trade Size (Sh.):	251
Avg Trade Size (Sh.) (30 D):	580
Avg Trade Size (Sh.) (90 D):	711

Institutional Trades
Total Institutional Trades:	35
Avg Institutional Trade:	$1.59M
Avg Institutional Trade (30 D):	$.55M
Avg Institutional Trade (90 D):	$.55M
Avg Institutional Trade Volume:	.05M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.91M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	31.93K

News

Dec 20, 2025 @ 4:26 PM Halper Sadeh LLC Encourages FOLD, VYNE, HTBK, FMNB... Source: Halper Sadeh Llc

Dec 17, 2025 @ 1:00 PM VYNE Therapeutics and Yarrow Bioscience Announce M... Source: Not Specified

Aug 14, 2025 @ 5:00 PM Vitiligo Clinical Trial Pipeline Accelerates as 18... Source: Delveinsight

Jun 26, 2024 @ 12:00 PM VYNE Therapeutics to Participate in Leerink Partne... Source: VYNE Therapeutics Inc.

Jun 14, 2024 @ 1:01 PM Analyst Scoreboard: 4 Ratings For VYNE Therapeutic... Source: Benzinga Insights

Financials
	TTM	Q1 2025	Q4 2024
Basic EPS	$-.13	$-.2	$-.28
Diluted EPS	$-.13	$-.2	$-.28
Revenue	$.07M	$.2M	$.08M
Gross Profit
Net Income / Loss	$-5.76M	$-8.61M	$-12.02M
Operating Income / Loss	$-7.54M	$-9.2M	$-12.77M
Cost of Revenue
Net Cash Flow	$-6.16M	$8.28M	$3.61M
PE Ratio

Splits
Feb 13, 2023	1:18
Feb 16, 2021	1:4